Literature DB >> 28362237

Ionizing radiation augments glioma tropism of mesenchymal stem cells.

Jonathan G Thomas1,2, Brittany C Parker Kerrigan1,3, Anwar Hossain1, Joy Gumin1, Naoki Shinojima1, Felix Nwajei1, Ravesanker Ezhilarasan4, Patrice Love4, Erik P Sulman4, Frederick F Lang1.   

Abstract

OBJECTIVE Mesenchymal stem cells (MSCs) have been shown to localize to gliomas after intravascular delivery. Because these cells home to areas of tissue injury, the authors hypothesized that the administration of ionizing radiation (IR) to tumor would enhance the tropism of MSCs to gliomas. Additionally, they sought to identify which radiation-induced factors might attract MSCs. METHODS To assess the effect of IR on MSC migration in vitro, transwell assays using conditioned medium (CM) from an irradiated commercially available glioma cell line (U87) and from irradiated patient-derived glioma stem-like cells (GSCs; GSC7-2 and GSC11) were employed. For in vivo testing, green fluorescent protein (GFP)-labeled MSCs were injected into the carotid artery of nude mice harboring orthotopic U87, GSC7-2, or GSC17 xenografts that were treated with either 0 or 10 Gy of IR, and brain sections were quantitatively analyzed by immunofluorescence for GFP-positive cells. These GSCs were used because GSC7-2 is a weak attractor of MSCs at baseline, whereas GSC17 is a strong attractor. To determine the factors implicated in IR-induced tropism, CM from irradiated GSC7-2 and from GSC11 was assayed with a cytokine array and quantitative ELISA. RESULTS Transwell migration assays revealed statistically significant enhanced MSC migration to CM from irradiated U87, GSC7-2, and GSC11 compared with nonirradiated controls and in a dose-dependent manner. After their intravascular delivery into nude mice harboring orthotopic gliomas, MSCs engrafted more successfully in irradiated U87 (p = 0.036), compared with nonirradiated controls. IR also significantly increased the tropism of MSCs to GSC7-2 xenografts (p = 0.043), which are known to attract MSCs only poorly at baseline (weak-attractor GSCs). Ionizing radiation also increased the engraftment of MSCs in strong-attractor GSC17 xenografts, but these increases did not reach statistical significance. The chemokine CCL2 was released by GSC7-2 and GSC11 after irradiation in a dose-dependent manner and mediated in vitro transwell migration of MSCs. Immunohistochemistry revealed increased CCL2 in irradiated GSC7-2 gliomas near the site of MSC engraftment. CONCLUSIONS Administering IR to gliomas enhances MSC localization, particularly in GSCs that attract MSCs poorly at baseline. The chemokine CCL2 appears to play a crucial role in the IR-induced tropism of MSCs to gliomas.

Entities:  

Keywords:  BBB = blood-brain barrier; CCL2; CM = conditioned medium; DMSO = dimethyl sulfoxide; EGF = epidermal growth factor; GBM = glioblastoma; GFP = green fluorescent protein; GSC = glioma stem-like cell; IR = ionizing radiation; MCP-1; MSC = mesenchymal stem cell; PBS = phosphate-buffered saline; PDGF = platelet-derived growth factor; TGF-β1 = transforming growth factor–β1; dH2O = deionized water; glioma; hMSC = human MSC; mesenchymal stem cells; oncology; radiation; α-MEM = α-minimum essential medium

Mesh:

Substances:

Year:  2017        PMID: 28362237      PMCID: PMC6008155          DOI: 10.3171/2016.9.JNS16278

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  43 in total

1.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

2.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect.

Authors:  Uwe M Fischer; Matthew T Harting; Fernando Jimenez; Werner O Monzon-Posadas; Hasen Xue; Sean I Savitz; Glen A Laine; Charles S Cox
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

3.  Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

Authors:  Mari Dezawa; Hiroto Ishikawa; Yutaka Itokazu; Tomoyuki Yoshihara; Mikio Hoshino; Shin-ichi Takeda; Chizuka Ide; Yo-ichi Nabeshima
Journal:  Science       Date:  2005-07-08       Impact factor: 47.728

4.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.

Authors:  S Y Leung; M P Wong; L P Chung; A S Chan; S T Yuen
Journal:  Acta Neuropathol       Date:  1997-05       Impact factor: 17.088

5.  Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro.

Authors:  Feng Xu; Jinlong Shi; Bin Yu; Wei Ni; Xing Wu; Zhikai Gu
Journal:  Oncol Rep       Date:  2010-06       Impact factor: 3.906

Review 6.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

7.  Vascular damage after fractionated whole-brain irradiation in rats.

Authors:  William R Brown; Clara R Thore; Dixon M Moody; Michael E Robbins; Kenneth T Wheeler
Journal:  Radiat Res       Date:  2005-11       Impact factor: 2.841

8.  Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.

Authors:  Travis H Stracker; Christian T Carson; Matthew D Weitzman
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

Review 9.  Immune modulation by ionizing radiation and its implications for cancer immunotherapy.

Authors:  Eric J Friedman
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

10.  Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters.

Authors:  Mir J Ali; Yot Navalitloha; Michael W Vavra; Eric W-Y Kang; Andrea C Itskovich; Peter Molnar; Robert M Levy; Dennis R Groothuis
Journal:  Neuro Oncol       Date:  2006-03-08       Impact factor: 12.300

View more
  17 in total

Review 1.  The evolution of stereotactic radiosurgery in neurosurgical practice.

Authors:  Daniel M Trifiletti; Henry Ruiz-Garcia; Alfredo Quinones-Hinojosa; Rohan Ramakrishna; Jason P Sheehan
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors.

Authors:  David Ruano; José A López-Martín; Lucas Moreno; Álvaro Lassaletta; Francisco Bautista; Maitane Andión; Carmen Hernández; África González-Murillo; Gustavo Melen; Ramón Alemany; Luis Madero; Javier García-Castro; Manuel Ramírez
Journal:  Mol Ther       Date:  2020-01-21       Impact factor: 11.454

3.  Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer.

Authors:  Alison R Mercer-Smith; Wulin Jiang; Juli R Bago; Alain Valdivia; Morrent Thang; Alex S Woodell; Stephanie A Montgomery; Kevin T Sheets; Carey K Anders; Shawn D Hingtgen
Journal:  Mol Cancer Ther       Date:  2021-08-25       Impact factor: 6.261

4.  Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the Accuracy.

Authors:  Heidi Marie Stoellinger; Arshak R Alexanian
Journal:  Assay Drug Dev Technol       Date:  2022-02-23       Impact factor: 1.738

5.  Next-generation Tumor-homing Induced Neural Stem Cells as an Adjuvant to Radiation for the Treatment of Metastatic Lung Cancer.

Authors:  Alison R Mercer-Smith; Andrew Buckley; Alain Valdivia; Wulin Jiang; Morrent Thang; Noah Bell; Rashmi J Kumar; Hunter N Bomba; Alex S Woodell; Jie Luo; Scott R Floyd; Shawn D Hingtgen
Journal:  Stem Cell Rev Rep       Date:  2022-04-19       Impact factor: 6.692

6.  Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.

Authors:  Francesca Puca; Fei Yu; Caterina Bartolacci; Piergiorgio Pettazzoni; Alessandro Carugo; Emmet Huang-Hobbs; Jintan Liu; Ciro Zanca; Federica Carbone; Edoardo Del Poggetto; Joy Gumin; Pushan Dasgupta; Sahil Seth; Sanjana Srinivasan; Frederick F Lang; Erik P Sulman; Philip L Lorenzi; Lin Tan; Mengrou Shan; Zachary P Tolstyka; Maureen Kachman; Li Zhang; Sisi Gao; Angela K Deem; Giannicola Genovese; Pier Paolo Scaglioni; Costas A Lyssiotis; Andrea Viale; Giulio F Draetta
Journal:  Cancer Discov       Date:  2021-05-26       Impact factor: 39.397

Review 7.  Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.

Authors:  Billy Samuel Hill; Alessandra Pelagalli; Nunzia Passaro; Antonella Zannetti
Journal:  Oncotarget       Date:  2017-08-14

8.  Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient.

Authors:  Lidia Franco-Luzón; Sandra García-Mulero; Rebeca Sanz-Pamplona; Gustavo Melen; David Ruano; Álvaro Lassaletta; Luís Madero; África González-Murillo; Manuel Ramírez
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

Review 9.  Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications.

Authors:  Kshama Gupta; Terry C Burns
Journal:  Front Oncol       Date:  2018-11-08       Impact factor: 6.244

10.  Liposomal Lapatinib in Combination with Low-Dose Photodynamic Therapy for the Treatment of Glioma.

Authors:  Carl Fisher; Girgis Obaid; Carolyn Niu; Warren Foltz; Alyssa Goldstein; Tayyaba Hasan; Lothar Lilge
Journal:  J Clin Med       Date:  2019-12-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.